Australia's largest stock trading and investment forum Australia's #1 stock forum

KZA

Click for more information

0.00%

8.0¢ kazia therapeutics limited

RPDD - priorty review vouchers, page-2

First 2 Last

Share
Profile

Follow
reon1

1,591 Posts.

521

07/07/22

08:52

Post #: 62413357
Share

Originally posted by reon1: ↑

I see a few posters seem to think KZA has already been awarded 2 PRVs which the company could sell any time now.

That is incorrect. We have 2 RPD designations for PAX. We only get a voucher if PAX is FIRST approved in the indication. So still years away yet.

We currently have no PRVs.

We will never receive more than 1 PRV for PAX, we just have 2 separate opportunities.

Given that GBM will likely be our first disease indication submitted for FDA approval making PAX ineligible for PRV, it is unlikely we will never get a PRV for PAX.

Expand

Sorry, correction. It is unlikely we will ever get a PRV for PAX.

KZA Price at posting: 62.0¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

IMU

Imugene kicks off Australian trial for blood cancer treatment

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

FG1

Flynn Gold reaches milestone exploration target for Golden Ridge

Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive

MMI

Metro Mining inks bauxite offtake contracts into 2026 with Chinese m

HotCopper Highlights: Your most watched and most discussed stocks this week

Trump Victory Sends Bitcoin Surging Above $75K – Is $100K Next?

Trump is President Again: What Does This Mean for Crypto?

UBI

Universal Biosensors flat despite fresh deal with US medical product distributor

There are more pages in this discussion • 12 more messages in this thread...

First 2 Last

Add KZA (ASX) to my watchlist